The exacerbation of tissue damage in the hyperacute and acute phase of AIS is mediated predominantly by CD14highCD16−CCR2high monocytes that secrete TNF-α, IL-1β, and IL-6. The gene discussed is IL1B; the disease is androgen insensitivity syndrome.